How to License Your Patent and Generate Revenue from Your Invention

What Patent Licensing Is — and What It Is Not

A patent grants you the right to exclude others from making, using, selling, or importing your invention. Licensing is the mechanism by which you authorize another party — the licensee — to exercise some or all of those rights in exchange for compensation. You remain the patent owner; you are granting permission, not transferring ownership.

Patent licensing is not the same as selling (assigning) your patent. An assignment is a permanent transfer of ownership; a license is a contractual permission that can be time-limited, field-limited, and revocable under specified conditions. The distinction matters for tax treatment, control, and strategic flexibility.

Licensing can generate revenue in two primary forms: upfront lump-sum payments (paid at signing or milestone events) and running royalties (a percentage of net sales or a fixed amount per unit sold). Most commercial licenses include both — an upfront fee that compensates the licensor for the value of access, and ongoing royalties that align incentives with actual commercialization.

Exclusive, Non-Exclusive, and Sole Licenses: Choosing the Right Structure

The scope of rights granted to the licensee is the most consequential structural decision in a patent license:

An exclusive license grants the licensee the right to use the patent to the exclusion of everyone else — including the patent owner. The licensee has the field to themselves. Exclusive licenses command the highest royalty rates and upfront fees because the licensee is taking on all commercial risk in that market. They typically also come with minimum royalty commitments (to prevent a licensee from sitting on the patent to block competition without actually commercializing it) and diligence obligations requiring active commercialization efforts.

A non-exclusive license grants permission to use the patent but does not limit the patent owner from licensing others in the same space. Non-exclusive licenses are typically priced lower but allow the licensor to generate income from multiple parties simultaneously. This structure is common in technology licensing programs where the goal is broad adoption rather than maximizing revenue from a single relationship.

A sole license is a hybrid: the licensee has exclusivity, but the patent owner retains the right to use the patent themselves. This structure works when a startup wants to license to one major commercial partner while retaining the ability to practice the invention in-house.

Finding Potential Licensees

Identifying the right licensee is as much a business development exercise as a legal one. A few productive approaches:

• Review who is already in the space. Companies currently selling products in your invention's market are often the best targets — they have the distribution infrastructure and customer relationships to commercialize immediately. Patent analytics databases (Derwent, PatSnap) can identify who is patenting in adjacent areas.
• Follow the supply chain. If your invention improves a component, target manufacturers who supply the relevant product category. If it improves a process, target the manufacturers who use that process.
• Look for companies that have licensed similar technology. A company that has already taken licenses in your space has demonstrated willingness to do so — they understand the value proposition and have internal approval processes for licensing deals.
• Industry associations and trade shows. Direct contact at industry events allows you to present the invention to the right decision-makers before involving legal teams, which lowers the initial friction.

Before outreach, ensure your patent is in order: issued, maintained, and with clean chain-of-title. A licensee's IP counsel will verify all of this before signing anything.

Negotiating Royalty Rates: Industry Benchmarks

Royalty rates vary significantly by industry, but understanding the ranges helps calibrate reasonable expectations:

• Consumer products: 2–5% of net sales
• Industrial / manufacturing: 3–7% of net sales
• Automotive components: 1–4% of net sales
• Pharmaceutical (branded): 6–15% of net sales (higher for blockbuster drugs)
• Software / technology: 5–15% of net sales (highly variable by leverage)
• Medical devices: 4–8% of net sales

The "25% rule" — that a royalty should equal roughly 25% of the licensee's anticipated profits on the invention — was a commonly cited starting point for royalty negotiations for decades, though it has been criticized by courts as oversimplified. A more rigorous approach uses the Georgia-Pacific factors (a 15-factor framework used in patent infringement damages analysis) as a negotiating framework. Key factors include the remaining patent term, the exclusivity of the license, existing licensing benchmarks, the commercial relationship between the parties, and the nature of the invention's contribution to the licensee's profits.

Key Terms in a Patent License Agreement

Beyond royalty rates, several terms in a patent license agreement have significant practical and legal consequences:

Field of use. Limiting the license to a specific field of use (e.g., "agricultural applications only") allows you to license the same patent to different parties in different fields, maximizing total revenue. Field restrictions must be carefully defined to avoid disputes over scope.

Territory. Most licenses are geographically limited. Ensure the territory aligns with where the licensee actually operates and that you retain rights to license in other territories.

Minimum royalties / minimum annual payments. These prevent a licensee from taking an exclusive license and then failing to commercialize, effectively blocking your ability to license to others. If the licensee does not reach the minimum, you typically have the right to terminate or convert to non-exclusive.

Sublicensing rights. Does the licensee have the right to sublicense to third parties? Sublicensing without the licensor's approval can result in the technology being placed in relationships and markets you did not anticipate. Require consent or at minimum accounting for sublicense revenue.

Improvements. Who owns improvements the licensee makes to the licensed technology during the license term? "Grant-back" provisions (requiring the licensee to license improvements back to the patent owner) are common but must be carefully drafted to avoid antitrust issues.

Enforcement obligations. If a third party infringes the patent, who has the obligation and right to enforce it? In an exclusive license, the licensee often has standing to sue infringers — but does the licensor have an obligation to sue if the licensee demands it? Enforcement provisions address cost allocation and control over litigation strategy.

Common Mistakes Inventors Make in Licensing Negotiations

Several patterns consistently undermine inventors' positions in licensing negotiations:

• Disclosing too much too early. Before any agreement is in place, sharing detailed technical information with a potential licensee without an NDA allows them to design around the patent or use the information competitively.
• Accepting the first offer. Licensees typically open negotiations with terms favorable to themselves. Understanding market benchmarks and having a clear walk-away position prevents leaving significant value on the table.
• Ignoring the audit right. Running royalties are only as good as your ability to verify them. Ensure the agreement includes a right to audit the licensee's books and records, with costs paid by the licensee if an underpayment of a defined threshold (commonly 5%) is discovered.
• No termination triggers. A license without clear termination rights for breach, non-payment, or failure to commercialize can become very difficult to exit. Ensure termination rights are clearly defined and that notice and cure periods are reasonable.
• Failing to address patent maintenance costs. Who pays USPTO maintenance fees during the license term? In exclusive licenses, it is common for the licensee to pay maintenance fees — but this needs to be explicit in the agreement.